drugset / Trial / NCT05925894

Efficacy Mydrane ® for Cataract Surgery in Patients With Concomitant Primary Open Angle Glaucoma.

NCT05925894 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to compare Mydrane ®, mydriatic eye drops and Mydriasert ® in terms of pupil site stability, surgical time, visual field and anterior chamber configuration modifications among primary open angle glaucoma (POAG) patients during cataract extraction surgery.

Timeline

Start
2021-03-18
Primary completion
2021-12-18
Completion
2022-01-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Mydrane Other / unclassified 0.2 ml Intrathecal

Indications